- TD-A Brief Overview of the More Common Indications for Lab Studies
- TD-A Modern Approach to Dry Eye
- TD-Advanced Procedures with RadioFrequency
- TD-Age Related Macular Degeneration - 2022 Update
- TD-AMD Updates: Staying Current with its Landscape
- TD-Anterior Segment Grand Rounds
- TD-Applications of Angiography (FA, ICG, OCTA)
- TD-Battle of the Omegas - Comparing Nutritional Strategies in Dry Eye Disease
- TD-Beauty Confidential
- TD-Benefits of Managing the Eyelid Margin in Meibomian Gland Dysfunction
- TD-Beyond the Posterior Pole
- TD-Caution Steep Hill Ahead: Managing Keratoconus in Clinical Practice: Are you Ready to Conquer Keratoconus?
- TD-Contemporary Diabetic Retinopathy Care
- TD-Contemporary Keratoconus
- TD-Corneal Collagen Crosslinking (CXL): MD and OD Perspective
- TD-Demodex Diaries
- TD-Eyelid Ptosis: Make the Right Diagnosis
- TD-From Retinal Findings to Systemic Diagnosis
- TD-How to Heal When You Can’t Feel – Neurotrophic Keratitis Update
- TD-Imaging the Anterior Segment
- TD-Innovations in Ocular Surface Disease to Maximize Patient Outcomes
- TD-Intravitreal Injections - What Optometry Should Know
- TD-Lids and Lashes on the Cutting Edge
- TD-Lumps and Bumps: A Practical Guide to Evaluation and Management
- TD-Minor Surgical Procedures
- TD-OCT Angiography Grand Rounds
- TD-On Call with Melton and Vollmer
- TD-Optometry & Genetics: The Future of Precision Medicine
- TD-Panel Discussion: Is There a Treatment for Me? Genetic Testing, Clinical Trials, Gene Therapy, & Future Treatments Q&A
- TD-Peeling Back the Layers: A Case Based Trip Around the Cornea
- TD-Retina OCT Workshop: How to Scan How to Interpret
- TD-Screening for Carcinoma of the Eyelids
- TD-Seeing White Dots
- TD-Sensitivity Training; A Chronicle of Neurotrophic Keratitis (NK) Management
- TD-Solving the Scleritis Dilemma
- TD-The Complete Course on Corneal Dystrophies and Degenerations
- TD-The Ocular Adnexa. Optometry's Next Frontier
- TD-Treatment Strategies for Refractory Ocular Surface Disease
- TD-Unraveling Intraocular Inflammation
- TD-Using IPL to address ocular surface and adnexal conditions
- TD-Worst Case Scenarios- A Co-Management Review of Ocular Trauma Emergencies from Pediatrics to Adults
TD-New Developments in Anti-VEGF Therapy
Description:
Anti-VEGF therapy has revolutionized the treatment of exudative retinal vascular disease. Whereas the first generations of anti-VEGF therapy hoped to improve quality of life through vision maintenance and remediation, newer advancement hope to decrease the burden of treatment while providing comparable visual outcomes. This course will briefly review current paradigms of anti-VEGF therapy before delving into novel anti-VEGF delivery systems and agents.
Course Code:
AOA344-TD
Speaker(s):
Daniel Epshtein, O.D.
Credits:
1
AOA Expiration Date:
12/2/2025
When to consider referring for low-vision rehabilitation
This Low Vision Awareness Month—and year-round—know when to refer, how to find the right provider and other considerations to help patients maintain their quality of life.
Bringing the optometric community together
The AOA announced its new Advocacy Network Partner Program and recognized Alan Glazier, O.D., the influential founder of ODs on Facebook, as its first advocacy network partner. Read more about the doctor of optometry behind the online community.
Cutting-edge education at Optometry’s Meeting® 2025 in Minneapolis
A global audience converges on the American Heartland for unmatched learning opportunities at Optometry’s Meeting®, June 25-28, in Minneapolis.